01.06.2024 International Scientific Journal "Science and Innovation". Series D. Volume 3 Issue 5
Abstract. Hyperprolactinemia is a common endocrine disorder, occurring in less than 1% of the general population. It can lead to a variety of reproductive health problems, including the risk of pregnancy complications such as habitual miscarriage. Recurrent pregnancy loss is a heterogeneous disorder affecting up to 2-5% of married couples
Keywords: hyperprolactinemia; habitual miscarriage; prolactin; inhibin; pregnancy.
1. Abdulkadyrova ZK, Abashova EI. Inhibin as a reproductive biomarker. Part 1. Journal of Obstetrics and Women’s Diseases. 2019;68(3):61-70. https://doi.org/10.17816/JOWD68361-70 2. Abdulkadyrova ZK, Yarmolinskaya MI, Gzgzyan AM, et al. Inhibin as a reproductive biomarker. Part 2. Clinical significance of inhibins in reproductive medicine. Journal of Obstetrics and Women’s Diseases. 2019;68(5):91-106. https://doi.org/10.17816/JOWD68591-106 3. Bernard V., Young J., Binart N. Prolactin – a pleiotropic factor in health and disease. Nat Rev Endocrinol/ 2019 Jun;15(6): 356-365. doi:10.1038/s41574-019-0194-6. PMID:30899100 4. Bronstein MD. Disorders of prolactin secretion and prolactinomas. In: DeGroot LJ, Jameson JL, editors. Endocrinology. 6th ed. Philadelphia: Saunders/Elsevier; 2010. pp. 333–57. 5. Bykanova K.S., Pigarova E.A. Hyperprolactinemia and pregnancy: main achievements and outstanding issues. Vestnik reproduktivnogo zdorov'ya. 2011; (1): 16—8. (in Russian) 6. Bykanova N.S., Pigarova E.A. Hyperprolactinemia and pregnancy: main achievements and outstanding issues. Vestnik reproduktivnogo zdorov'ya. 2011; (1): 18—21. (in Russian) 7. Chester M.R., Tirlapur A. and Jayaprakasan K. (2022), Current management of recurrent pregnancy loss. Obstet Gynecol,24: 260-271. https://doi.org/10.1111/tog.12832 8. Ciarmela P, Florio P, Toti P, et al. Expression of betaglycan in pregnant issues throughout gestation. Eur J Endocrinol. 2003:433-437 https://doi.org/10.1530/eje.0.1490433. 9. Erol O, Süren D, Tutuş B, et al. Immunohistochemical analysis of E-cadherin, p53 and inhibin-α expression in hydatidiform mole and hydropic abortion. Pathol Oncol Res. 2016;22(3):515-521. https://doi.org/10.1007/s12253-015-0031-8. 10. European Society of Human Reproduction and Embryology (ESHRE). Recurrent pregnancy loss. Strombeek-Bever: ESHRE; 2017 https://www.eshre.eu/Guidelines-and-Legal/Guidelines/Recurrent-pregnancy-loss.aspx Google Scholar 11. Grattan D.K., Kokay I.C. Prolactin: a pleiotropic neuroendocrine hormone. J. Neuroendocrinol. 2008; 20(6): 752-63 12. Hauzman E, Murber A, Fancsovits P, et al. [Use of biochemical markers to predict the outcome of pregnancies conceived by in vitro fertilization. (In Hungarian)]. Orv Hetil.2006;147(30):1409-1420. https://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg17 13. Ivan I. Dedov, Galina A. Melnichenko, Larisa K. Dzeranova, Elena N. Andreeva, Elena N. Grineva, Evgenia I. Marova, Natalia G. Mokrysheva, Ekaterina A. Pigarova, et al. Clinical guidelines ‘hyperprolactinemia’ (draft). Obesity and metabolism — 2023. —Т. 20. — №2. — P. 170-188. doi: https://doi.org/10.14341/omet13002 14. Jones RL, Salamonsen LA, Critchley HO, et al. Inhibin and activin subunits are differentially expressed in endometrial cells and leukocytes during the menstrual cycle, in early pregnancy and in women using progestin-only contraception. Mol Hum Reprod. 2000;6(12):1107-1117.https://doi.org/10.1093/molehr/6.12.1107 15. Jones RL, Salamonsen LA, Critchley HO, et al. Inhibin and activin subunits are differentially expressed in endometrial cells and leukocytes during the menstrual cycle, in early pregnancy and in women using progestin-only contraception. Mol Hum Reprod. 2000;6(12):1107-1117.https://doi.org/10.1093/molehr/6.12.1107 16. L.K. Dzeranova, N.S. Bykanova, E.A. Pigarova Hyperprolactinemia and pregnancy: the basic achievements and unresolved problems// Bulletin of reproductive health// 2009.№1. 17. Larina A.A., Grigoryan O.V., Andreeva E.N., Dzeranova L.K. Hyperprolactinemia and pregnancy. Problemy reproduktsii. 2013; (3): 13—7. (in Russian) 18. Lucio Vilar, Clarice Freitas Vilar, Ruy Lyra, Maria da Conceição Freitas. Neuroendocrinology 2019;109:7–19. Pitfalls in the Diagnostic Evaluation of Hyperprolactinemia/ DOI: 10.1159/000499694 19. Luisi S, Florio P, DʼAntona D, et al. Maternal serum inhibin A levels are a marker of a viable trophoblast in incomplete and complete miscarriage. Eur J Endocrinol. 2003;148(2):233-236. https://doi.org/10.1530/eje.0.1480233. 20. Majeed H, Højgaard A, Johannesen P, et al. Predictive value of serum human chorionic gonadotropin ratio, progesterone and inhibin A for expectant management of early pregnancies of unknown location. Eur J Obstet Gynecol Reprod Biol. 2012;165(1):66-69. https://doi.org/10.1016/j.ejogrb.2012.07.020. 21. Majumdar A, Mangal NS. Hyperprolactinemia. J Hum Reprod Sci. 2013 Jul;6(3):168-75. doi: 10.4103/0974-1208.121400. PMID: 24347930; PMCID: PMC3853872. 22. Melmed S, Casanueva FF, Hoffman AR, et al. Diagnosis and treatment of hyperprolactinemia: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(2):273-288. doi: https://doi.org/10.1210/jc.2010-1692 23. Molitch M. Prolactinomas and pregnancy. Clin. Endocrinol. (Oxford). 2010; 73(2): 147—8. 24. Muttukrishna S, George L, Fowler PA, et al. Measurement of serum concentrations of inhibin-A (α-β A dimer) during human pregnancy. Clin Endocrinol (Oxf). 1995;42(4):391-397. https://doi.org/10.1111/j.1365-2265.1995.tb02648.x. 25. Namwanje M, Brown CW. Activins and Inhibins: Roles in Development, Physiology, and Disease. Cold Spring Harb Perspect Biol. 2016;8(7):a021881.https://doi.org/10.1101/cshperspect.a021881 26. Pankov Yu.A. New signating systems in hormonal regulation mechanisms. Problems of Endocrinology. 2000 №2.– С.3-8. http://doi.org/10.14341/probl11837 27. Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril 2012; 98: 1103–11. 28. Prolactin: Structure, function, and regulation of secretion/ M.E.Freeman, B. Kanyicsa, A. Lerent et al./Physiol Rev-2000/ - V.80, N.4. – P.1523-1631 29. Rausch ME, Sammel MD, Takacs P, et al. Development of a multiple marker test for ectopic pregnancy. Obstet Gynecol. 2011;117(3):573-582.https://doi.org/10.1097/AOG.0b013e31820b3c61. 30. Royal College of Obstetricians and Gynaecologists (RCOG). The investigation and treatment of couples with recurrent first-trimester and second-trimester miscarriage. Green-top guideline No. 17. London: RCOG; 2011 31. Ruiz-Herrera X, de Los Rios EA, Diaz JM et al (2017) Prolactin promotes adipose tissue fitness and insulin sensitivity in mice via STAT5. Diabetes 62:3103-3113 32. Saleem M, Martin H, Coates P. Prolactin Biology and Laboratory Measurement: An Update on Physiology and Current Analytical Issues. Clin Biochem Rev. 2018 Feb;39(1):3-16. PMID: 30072818; PMCID: PMC6069739. 33. Sebko T.V., Kheydar L.A., Koneeva S.S. The hyperprolactinemia. Rossiiskii meditsinskii zhournal (Medical Journal of the Russian Federation, Russian journal). 2016; 22(5): 250—259 (In Russ.). DOI 10.18821/0869-2106-2016-22-5-250-259 34. Segal S, Gor H, Correa N, et al. Inhibin A: marker for diagnosis of ectopic and early abnormal pregnancies. Reprod Biomed Online. 2008;17(6):789 794. https://doi.org/10.1016/s1472-6483(10)60406-3. 35. Shloma M., Richard J.F., Allison B.G., Ronald J.K., Clifford J.R. «Williams Textbook of Endocrinology” 14th edition 2020 by Elseviar., 191-196. 36. Sosnova E.A. Hyperprolactinemic syndrome. V.F. Snegirev Archives of Obstetrics and Gynecology, Russian journal. 2017; 4(1): 4—14. (In Russ.).DOI: http://dx.doi.org/10.18821/2313¬8726¬2017¬4¬1¬4¬14 37. Stenvers KL, Findlay JK. Inhibins and activins: towards the future. A tribute to the late Professor Wylie W. Vale. Mol Cell Endocrinol. 2012;359(1-2):1.https://doi.org/10.1016/j.mce.2012.03.001 38. Thapa S, Bhusal K. Hyperprolactinemia. 2023 Jul 24. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 30726016. 39. Treetampinich C, O’Connor AE, MacLachlan V, et al. Maternal serum inhibin A concentrations in early pregnancy after IVF and embryo transfer reflect the corpus luteum contribution and pregnancy outcome. Hum Reprod. 2000;15(9):2028-2032. https://doi.org/10.1093/humrep/15.9.2028. 40. Turasheva A., Aimagambetova G., Ukybassova T., and et al. 2023. «Recurrent pregnancy loss etiology, risk factors, diagnosis, and management. Fresh look into a full box» Journal of clinical medicine 12, no.12:4074https://doi.org/10.3390/jcm12124074 41. Vilar L, Fleseriu M, Bronstein MD. Challenges and pitfalls in the diagnosis of hyperprolactinemia. Arq Bras Endocrinol Metabol. 2014 Feb; 58(1): 9–22. 42. Wijayarathna R, de Kretser DM. Activins in reproductive biology and beyond. Hum Reprod Update. 2016;22(3):342- 357.https://doi.org/10.1093/humupd/dmv058. 43. https://www.rmj.ru/articles/akusherstvo/Nerazvivayuschayasya_beremennosty_i_giperprolaktinemiya_Esty_li_mesto_rastitelynym_preparatam_v_terapii/#ixzz8ZozpfcCW 44. https://obgynkey.com/endocrine-abnormalities-in-rpl/ 45. https://www.researchgate.net/publication/291410495 46. .https://www.dissercat.com/content/prolaktinovye-narusheniya-i-ikh-rol-vformirovanii-reproduktivnogo-zdorovya-zhenshchin 47. Mirzaeva U. Z., Ismailov S. I., Nasyrova Kh. K. DISORDERS OF CARBOHYDRATE METABOLISM IN COVID-19 PATIENTS //BARQARORLIK VA YETAKCHI TADQIQOTLAR ONLAYN ILMIY JURNALI. – 2022. – T. 2. – No. 9. – pp. 117-122. 48. Nasyrova Kh. K., Mirzaeva U. Z., Muhammedaminova D. T. FREQUENCY OF HYPERPROLACTINEMIC SYNDROME IN WOMEN OF REPRODUCTIVE AGE // Journal of scientific publications of graduate students and doctoral students. – 2018. – No. 1. – pp. 38-42. 49. Nasyrova Kh. K., Khalimova Z. Yu., Ismailov S. I. International Journal of Endocrinology 5 (29) 2010. 50. Nasyrova Kh. K., Mirzaeva U. Z., Muhammedaminova D. T. FREQUENCY OF HYPERPROLACTINEMIC SYNDROME IN WOMEN OF REPRODUCTIVE AGE // Journal of scientific publications of graduate students and doctoral students. – 2018. – No. 1. – pp. 38-42. 51. Nasyrova Kh. K. et al. Comparative assessment of cytological examination of mixed saliva in pituitary adenomas // Postgraduate doctor. – 2010. – T. 38. – No. 1. – pp. 42-46.
SCIENCE & INNOVATION